Where can we add value?
Resistance to antibiotics is a major source of concern. The design of novel multivalent vaccines, prebiotics and non-antibiotic formulations based on modified bacteria can undoubtedly contribute to reduce the use of antibiotics and be essential to implant novel farm management procedures.
Since recombinant insuline was approved in 1982, Genetic engineering in pharmaceutics (known as “pharming”) is widely used for the production of innumerable biologics. Thousands of chemical steps could never lead to the perfection and complexity obtained by biofactories like bacteria, yeast or mammal cells.
The use of genetic engineering to create organisms specifically designed for bioremediation and bioleaching has great potential. Genetic engineered bacteria can also be used for the production of energy, fuels and chemicals from waste products.
Engineered bacteria can optimize agroalimentary industrial processes, such as the production of alcoholic drinks, bakery and dairy products production, food processing and so on. Besides, the use of novel synthetic metabolic pathways can add nutritional and organoleptic properties to products.
Genetic engineering can help to develop and produce novel and cost-effective compounds with anti-age, anti-dandruff or skin-protectant properties.
And many more!
RECOMBINA’s genetic engineering customized services might be applicable for every process where bacteria or yeast were involved.